Researching ME/CFS: priority area
UKRI/MRC funds multidisciplinary research into ME/CFS, focusing on disease mechanisms, diagnostics, treatment, and patient involvement to advance understanding and improve outcomes.
Funder: UK Research and Innovation
Due Dates: Open (no closing date)
Funding Amounts: Typically funds up to 80% of full economic cost (FEC); award size and duration depend on the selected MRC scheme.
Summary: Supports high-quality, multidisciplinary research into ME/CFS, prioritizing disease mechanisms, diagnostics, treatment, and patient involvement.
Key Information: Apply through any open MRC grant or fellowship scheme; strong encouragement for collaboration and public/patient engagement.
Description
This funding opportunity supports research into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), aiming to advance scientific understanding and improve diagnosis, management, and treatment options. Researchers are encouraged to address key scientific questions identified by the ME/CFS Priority Setting Partnership, including biological mechanisms, repurposing existing drugs, development of diagnostic tools, immune system involvement, disease stratification, post-infection disease evaluation, neurological and genetic factors, severity drivers, and mitochondrial or oxygenation dysfunction. Multidisciplinary collaboration, capacity building, and meaningful engagement with people living with ME/CFS are strongly encouraged. Applications can be submitted under any relevant Medical Research Council (MRC) scheme, including research grants and fellowships.
